Thus, in contrast with the glycolytic phenotype of BRAF-like PTCs, RAS-like tumours display expression signatures compatible with oxidative metabolism [47], characterised by the usage of extracellular lactate to produce ATP (via OXPHOS). The gene discussed is BRAF; the disease is neoplasm.